IVECO GROUP NV (IVG.MI) Fundamental Analysis & Valuation

BIT:IVG • NL0015000LU4

Current stock price

19.71 EUR
+0.34 (+1.76%)
Last:

This IVG.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. IVG.MI Profitability Analysis

1.1 Basic Checks

  • IVG had positive earnings in the past year.
  • IVG had a positive operating cash flow in the past year.
  • Each year in the past 5 years IVG has been profitable.
  • In the past 5 years IVG always reported a positive cash flow from operatings.
IVG.MI Yearly Net Income VS EBIT VS OCF VS FCFIVG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

1.2 Ratios

  • IVG has a Return On Assets of 1.53%. This is comparable to the rest of the industry: IVG outperforms 40.74% of its industry peers.
  • IVG has a Return On Equity of 10.47%. This is in the better half of the industry: IVG outperforms 63.89% of its industry peers.
  • IVG has a worse Return On Invested Capital (3.64%) than 62.04% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for IVG is below the industry average of 8.67%.
Industry RankSector Rank
ROA 1.53%
ROE 10.47%
ROIC 3.64%
ROA(3y)1.5%
ROA(5y)1.15%
ROE(3y)10.89%
ROE(5y)8.24%
ROIC(3y)4.03%
ROIC(5y)3.56%
IVG.MI Yearly ROA, ROE, ROICIVG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • With a Profit Margin value of 2.08%, IVG perfoms like the industry average, outperforming 40.74% of the companies in the same industry.
  • In the last couple of years the Profit Margin of IVG has grown nicely.
  • IVG's Operating Margin of 4.22% is in line compared to the rest of the industry. IVG outperforms 41.67% of its industry peers.
  • IVG's Operating Margin has improved in the last couple of years.
  • With a Gross Margin value of 16.02%, IVG is not doing good in the industry: 92.59% of the companies in the same industry are doing better.
  • IVG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.22%
PM (TTM) 2.08%
GM 16.02%
OM growth 3Y5.96%
OM growth 5YN/A
PM growth 3Y28.1%
PM growth 5YN/A
GM growth 3Y3.95%
GM growth 5Y11.26%
IVG.MI Yearly Profit, Operating, Gross MarginsIVG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. IVG.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so IVG is destroying value.
  • The number of shares outstanding for IVG has been increased compared to 1 year ago.
  • Compared to 5 years ago, IVG has more shares outstanding
  • The debt/assets ratio for IVG has been reduced compared to a year ago.
IVG.MI Yearly Shares OutstandingIVG.MI Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
IVG.MI Yearly Total Debt VS Total AssetsIVG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.67, we must say that IVG is in the distress zone and has some risk of bankruptcy.
  • IVG's Altman-Z score of 1.67 is on the low side compared to the rest of the industry. IVG is outperformed by 63.89% of its industry peers.
  • A Debt/Equity ratio of 1.37 is on the high side and indicates that IVG has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.37, IVG is not doing good in the industry: 81.48% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Altman-Z 1.67
ROIC/WACC0.5
WACC7.32%
IVG.MI Yearly LT Debt VS Equity VS FCFIVG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • IVG has a Current Ratio of 2.04. This indicates that IVG is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of IVG (2.04) is better than 75.00% of its industry peers.
  • IVG has a Quick Ratio of 1.59. This is a normal value and indicates that IVG is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 1.59, IVG belongs to the best of the industry, outperforming 82.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 1.59
IVG.MI Yearly Current Assets VS Current LiabilitesIVG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. IVG.MI Growth Analysis

3.1 Past

  • The earnings per share for IVG have decreased strongly by -44.23% in the last year.
  • Measured over the past years, IVG shows a very strong growth in Earnings Per Share. The EPS has been growing by 34.20% on average per year.
  • IVG shows a decrease in Revenue. In the last year, the revenue decreased by -8.94%.
  • Measured over the past years, IVG shows a small growth in Revenue. The Revenue has been growing by 5.22% on average per year.
EPS 1Y (TTM)-44.23%
EPS 3Y34.2%
EPS 5YN/A
EPS Q2Q%-36.73%
Revenue 1Y (TTM)-8.94%
Revenue growth 3Y-2.21%
Revenue growth 5Y5.22%
Sales Q2Q%-23.06%

3.2 Future

  • Based on estimates for the next years, IVG will show a very strong growth in Earnings Per Share. The EPS will grow by 47.56% on average per year.
  • IVG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.92% yearly.
EPS Next Y83.86%
EPS Next 2Y49.92%
EPS Next 3Y47.56%
EPS Next 5YN/A
Revenue Next Year9.13%
Revenue Next 2Y7.57%
Revenue Next 3Y9.92%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IVG.MI Yearly Revenue VS EstimatesIVG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
IVG.MI Yearly EPS VS EstimatesIVG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

6

4. IVG.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 16.99, which indicates a correct valuation of IVG.
  • 72.22% of the companies in the same industry are more expensive than IVG, based on the Price/Earnings ratio.
  • IVG's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.89.
  • A Price/Forward Earnings ratio of 9.24 indicates a reasonable valuation of IVG.
  • Based on the Price/Forward Earnings ratio, IVG is valued cheaply inside the industry as 91.67% of the companies are valued more expensively.
  • IVG is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.50, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.99
Fwd PE 9.24
IVG.MI Price Earnings VS Forward Price EarningsIVG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 74.07% of the companies in the same industry are more expensive than IVG, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.41
IVG.MI Per share dataIVG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as IVG's earnings are expected to grow with 47.56% in the coming years.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y49.92%
EPS Next 3Y47.56%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. IVG.MI Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.70%, IVG has a reasonable but not impressive dividend return.
  • IVG's Dividend Yield is a higher than the industry average which is at 1.40.
  • IVG's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.7%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • IVG pays out 30.45% of its income as dividend. This is a sustainable payout ratio.
DP30.45%
EPS Next 2Y49.92%
EPS Next 3Y47.56%
IVG.MI Yearly Income VS Free CF VS DividendIVG.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M -400M 600M
IVG.MI Dividend Payout.IVG.MI Dividend Payout, showing the Payout Ratio.IVG.MI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IVG.MI Fundamentals: All Metrics, Ratios and Statistics

IVECO GROUP NV

BIT:IVG (4/17/2026, 7:00:00 PM)

19.71

+0.34 (+1.76%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners36.74%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap5.35B
Revenue(TTM)13.92B
Net Income(TTM)289.00M
Analysts67.69
Price Target20.04 (1.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.7%
Yearly Dividend0.26
Dividend Growth(5Y)N/A
DP30.45%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-59.74%
Min EPS beat(2)-69.38%
Max EPS beat(2)-50.09%
EPS beat(4)1
Avg EPS beat(4)-32.27%
Min EPS beat(4)-69.38%
Max EPS beat(4)5.84%
EPS beat(8)5
Avg EPS beat(8)13.98%
EPS beat(12)6
Avg EPS beat(12)-1.45%
EPS beat(16)8
Avg EPS beat(16)-2.92%
Revenue beat(2)0
Avg Revenue beat(2)-10.32%
Min Revenue beat(2)-10.33%
Max Revenue beat(2)-10.31%
Revenue beat(4)1
Avg Revenue beat(4)-5.55%
Min Revenue beat(4)-10.33%
Max Revenue beat(4)8.56%
Revenue beat(8)4
Avg Revenue beat(8)-2.11%
Revenue beat(12)5
Avg Revenue beat(12)-1.67%
Revenue beat(16)9
Avg Revenue beat(16)1.21%
PT rev (1m)-0.32%
PT rev (3m)-0.32%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-17.24%
EPS NY rev (1m)-0.65%
EPS NY rev (3m)-1.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.68%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.16%
Valuation
Industry RankSector Rank
PE 16.99
Fwd PE 9.24
P/S 0.38
P/FCF N/A
P/OCF 6.9
P/B 1.94
P/tB 7.94
EV/EBITDA 6.41
EPS(TTM)1.16
EY5.89%
EPS(NY)2.13
Fwd EY10.82%
FCF(TTM)0
FCFYN/A
OCF(TTM)2.86
OCFY14.5%
SpS51.33
BVpS10.18
TBVpS2.48
PEG (NY)0.2
PEG (5Y)N/A
Graham Number16.2972 (-17.32%)
Profitability
Industry RankSector Rank
ROA 1.53%
ROE 10.47%
ROCE 4.43%
ROIC 3.64%
ROICexc 4.65%
ROICexgc 5.81%
OM 4.22%
PM (TTM) 2.08%
GM 16.02%
FCFM N/A
ROA(3y)1.5%
ROA(5y)1.15%
ROE(3y)10.89%
ROE(5y)8.24%
ROIC(3y)4.03%
ROIC(5y)3.56%
ROICexc(3y)5.01%
ROICexc(5y)4.33%
ROICexgc(3y)6%
ROICexgc(5y)5.15%
ROCE(3y)4.89%
ROCE(5y)4.32%
ROICexgc growth 3Y-0.39%
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.46%
ROICexc growth 5YN/A
OM growth 3Y5.96%
OM growth 5YN/A
PM growth 3Y28.1%
PM growth 5YN/A
GM growth 3Y3.95%
GM growth 5Y11.26%
F-Score4
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF N/A
Debt/EBITDA 2.86
Cap/Depr 105.3%
Cap/Sales 5.57%
Interest Coverage 250
Cash Conversion 58.58%
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 1.59
Altman-Z 1.67
F-Score4
WACC7.32%
ROIC/WACC0.5
Cap/Depr(3y)136.01%
Cap/Depr(5y)129.25%
Cap/Sales(3y)6.09%
Cap/Sales(5y)5.63%
Profit Quality(3y)122.53%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.23%
EPS 3Y34.2%
EPS 5YN/A
EPS Q2Q%-36.73%
EPS Next Y83.86%
EPS Next 2Y49.92%
EPS Next 3Y47.56%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.94%
Revenue growth 3Y-2.21%
Revenue growth 5Y5.22%
Sales Q2Q%-23.06%
Revenue Next Year9.13%
Revenue Next 2Y7.57%
Revenue Next 3Y9.92%
Revenue Next 5YN/A
EBIT growth 1Y-37.49%
EBIT growth 3Y3.63%
EBIT growth 5YN/A
EBIT Next Year128.11%
EBIT Next 3Y46.05%
EBIT Next 5YN/A
FCF growth 1Y-100%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-52.22%
OCF growth 3Y-18.03%
OCF growth 5Y6.75%

IVECO GROUP NV / IVG.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for IVECO GROUP NV?

ChartMill assigns a fundamental rating of 5 / 10 to IVG.MI.


What is the valuation status for IVG stock?

ChartMill assigns a valuation rating of 6 / 10 to IVECO GROUP NV (IVG.MI). This can be considered as Fairly Valued.


How profitable is IVECO GROUP NV (IVG.MI) stock?

IVECO GROUP NV (IVG.MI) has a profitability rating of 5 / 10.


What are the PE and PB ratios of IVECO GROUP NV (IVG.MI) stock?

The Price/Earnings (PE) ratio for IVECO GROUP NV (IVG.MI) is 16.99 and the Price/Book (PB) ratio is 1.94.


What is the expected EPS growth for IVECO GROUP NV (IVG.MI) stock?

The Earnings per Share (EPS) of IVECO GROUP NV (IVG.MI) is expected to grow by 83.86% in the next year.